Brenntag (BNR) Receives Average Recommendation of “Buy” from Brokerages

Shares of Brenntag (FRA:BNR) have been assigned a consensus recommendation of “Buy” from the nineteen analysts that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is €57.71 ($70.38).

BNR has been the subject of several recent research reports. Nord/LB set a €51.00 ($62.20) target price on shares of Brenntag and gave the company a “neutral” rating in a research report on Tuesday, March 20th. UBS set a €53.00 ($64.63) target price on shares of Brenntag and gave the company a “neutral” rating in a research report on Monday, February 5th. Commerzbank set a €59.00 ($71.95) target price on shares of Brenntag and gave the company a “neutral” rating in a research report on Wednesday, March 14th. Baader Bank set a €62.00 ($75.61) target price on shares of Brenntag and gave the company a “buy” rating in a research report on Thursday, March 1st. Finally, Goldman Sachs set a €54.00 ($65.85) target price on shares of Brenntag and gave the company a “neutral” rating in a research report on Friday, March 23rd.

Shares of Brenntag stock opened at €47.99 ($58.52) on Monday. Brenntag has a 1-year low of €43.06 ($52.51) and a 1-year high of €56.25 ($68.60).

About Brenntag

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply